Egil Johnson

3.2k total citations
112 papers, 2.6k citations indexed

About

Egil Johnson is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Egil Johnson has authored 112 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Surgery, 27 papers in Pulmonary and Respiratory Medicine and 27 papers in Immunology. Recurrent topics in Egil Johnson's work include Complement system in diseases (22 papers), Esophageal and GI Pathology (18 papers) and Fungal Biology and Applications (16 papers). Egil Johnson is often cited by papers focused on Complement system in diseases (22 papers), Esophageal and GI Pathology (18 papers) and Fungal Biology and Applications (16 papers). Egil Johnson collaborates with scholars based in Norway, Denmark and United States. Egil Johnson's co-authors include Geir Hetland, Soosaipillai V. Bernardshaw, Torstein Lyberg, Erik Carlsen, Bjørn Grinde, T. ESKELAND, Richard J. Heald, Ellen Schlichting, I. Guldvog and Hans‐Olaf Johannessen and has published in prestigious journals such as PLoS ONE, Thorax and Nutrients.

In The Last Decade

Egil Johnson

111 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Egil Johnson Norway 31 703 592 564 503 438 112 2.6k
Ki‐Baik Hahm South Korea 33 805 1.1× 175 0.3× 1.0k 1.8× 367 0.7× 395 0.9× 85 2.6k
Ki Baik Hahm South Korea 29 1.3k 1.8× 171 0.3× 828 1.5× 335 0.7× 489 1.1× 174 3.1k
Dong Shang China 26 596 0.8× 112 0.2× 802 1.4× 403 0.8× 607 1.4× 99 2.1k
Tadao Bamba Japan 33 1.0k 1.5× 149 0.3× 1.3k 2.2× 1.1k 2.1× 665 1.5× 160 4.2k
Jenn‐Haung Lai Taiwan 31 147 0.2× 221 0.4× 825 1.5× 887 1.8× 271 0.6× 83 2.7k
Lin Zhou China 38 321 0.5× 197 0.3× 1.9k 3.3× 868 1.7× 1.2k 2.8× 149 4.1k
Rupesh Chaturvedi United States 31 896 1.3× 251 0.4× 1.3k 2.3× 787 1.6× 405 0.9× 61 2.9k
Sharon Page Germany 21 546 0.8× 179 0.3× 1.1k 1.9× 1.3k 2.5× 461 1.1× 32 3.5k
Yuji Ikeda Japan 13 458 0.7× 109 0.2× 785 1.4× 584 1.2× 274 0.6× 83 2.2k
Bing Wan China 27 361 0.5× 153 0.3× 961 1.7× 878 1.7× 595 1.4× 102 2.9k

Countries citing papers authored by Egil Johnson

Since Specialization
Citations

This map shows the geographic impact of Egil Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Egil Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Egil Johnson more than expected).

Fields of papers citing papers by Egil Johnson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Egil Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Egil Johnson. The network helps show where Egil Johnson may publish in the future.

Co-authorship network of co-authors of Egil Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Egil Johnson. A scholar is included among the top collaborators of Egil Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Egil Johnson. Egil Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pinto, Rita, Marine Jeanmougin, Stine H. Kresse, et al.. (2022). Targeted genetic and epigenetic profiling of esophageal adenocarcinomas and non-dysplastic Barrett’s esophagus. Clinical Epigenetics. 14(1). 77–77. 5 indexed citations
2.
Løberg, Else Marit, et al.. (2020). Outcome after endoscopic treatment for dysplasia and superficial esophageal cancer – a cohort study. Scandinavian Journal of Gastroenterology. 55(9). 1132–1138. 1 indexed citations
3.
Løberg, Else Marit, et al.. (2016). Reseksjon for oesophaguscancer – komplikasjoner og overlevelse. Tidsskrift for Den norske legeforening. 136(9). 809–813. 3 indexed citations
5.
Vogel, Lotte K., Mona Sæbø, Helle Høyer, et al.. (2014). Intestinal PTGS2 mRNA Levels, PTGS2 Gene Polymorphisms, and Colorectal Carcinogenesis. PLoS ONE. 9(8). e105254–e105254. 34 indexed citations
6.
Johnson, Egil, et al.. (2014). Kirurgisk behandling av epifrenisk oesophagusdivertikkel. Tidsskrift for Den norske legeforening. 134(10). 1047–1050. 7 indexed citations
7.
Gondal, Ghous, Egil Johnson, Vemund Paulsen, & Hasan Banitalebi. (2010). Behandling av nøytropen enterokolitt. Tidsskrift for Den norske legeforening. 130(2). 143–145. 1 indexed citations
8.
Lunde, O. C., et al.. (2009). Long‐term functional outcome and quality of life after restorative proctocolectomy with ileo‐anal anastomosis for colitis. Colorectal Disease. 13(4). 431–437. 35 indexed citations
9.
Bernardshaw, Soosaipillai V., Torstein Lyberg, Geir Hetland, & Egil Johnson. (2007). Effect of an extract of the mushroom Agaricus blazei Murill on expression of adhesion molecules and production of reactive oxygen species in monocytes and granulocytes in human whole blood ex vivo. Apmis. 115(6). 719–725. 25 indexed citations
10.
Skjelbred, Camilla Furu, Mona Sæbø, Håkan Wallin, et al.. (2006). Polymorphisms of the XRCC1, XRCC3 and XPDgenes and risk of colorectal adenoma and carcinoma, in a Norwegian cohort: a case control study. BMC Cancer. 6(1). 67–67. 99 indexed citations
11.
Johnson, Egil, et al.. (2005). Kirurgi og stenting for cancer oesophagi. Tidsskrift for Den Norske Laegeforening. 1 indexed citations
12.
Bernardshaw, Soosaipillai V., Egil Johnson, & Geir Hetland. (2005). An Extract of the Mushroom Agaricus blazei Murill Administered Orally Protects Against Systemic Streptococcus pneumoniae Infection in Mice. Scandinavian Journal of Immunology. 62(4). 393–398. 61 indexed citations
13.
Bakken, Inger Johanne, Finn Egil Skjeldestad, Odd Mjåland, & Egil Johnson. (2003). Appendisitt og appendektomi i Norge 1990 – 2001. Tidsskrift for Den Norske Laegeforening. 2 indexed citations
14.
15.
Berge, Viktor, Knut Erik Berge, & Egil Johnson. (1996). Vitronectin modulates the expression of complement components of the terminal pathway synthesized by human umbilical vein endothelial cells in vitro. Apmis. 104(7-8). 523–530. 2 indexed citations
16.
Johnson, Egil, Viktor Berge, & Kolbjørn Högåsen. (1994). Formation of the Terminal Complement Complex on Agarose Beads: Further Evidence that Vitronectin (Complement S‐Protein) Inhibits C9 Polymerization. Scandinavian Journal of Immunology. 39(3). 281–285. 10 indexed citations
18.
Johnson, Egil, et al.. (1990). Quantification of Non‐Activated (Native) Complement Component C9 Synthesized by Alveolar Macrophages from Patients with Sarcoidosis. Scandinavian Journal of Immunology. 31(5). 657–663. 3 indexed citations
19.
Johnson, Egil & Geir Hetland. (1988). A sensitive method to detect synthesis of the functional classical, alternative and terminal pathway of complement by cells culturedin vitro. Scandinavian Journal of Clinical and Laboratory Investigation. 48(3). 223–231. 9 indexed citations
20.
Johnson, Egil, et al.. (1988). Synthesis of Soluble C3 and C9 Neoepitopes by Human Alveolar Macrophages in Vitro. Scandinavian Journal of Immunology. 28(4). 431–434. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026